DD203907A5 - Verfahren zur herstellung von 7-brom-5-(2-halogenphenyl)-1h-2,3 dihydro-1,4-benzodiazepin-verbindungen - Google Patents

Verfahren zur herstellung von 7-brom-5-(2-halogenphenyl)-1h-2,3 dihydro-1,4-benzodiazepin-verbindungen Download PDF

Info

Publication number
DD203907A5
DD203907A5 DD82243528A DD24352882A DD203907A5 DD 203907 A5 DD203907 A5 DD 203907A5 DD 82243528 A DD82243528 A DD 82243528A DD 24352882 A DD24352882 A DD 24352882A DD 203907 A5 DD203907 A5 DD 203907A5
Authority
DD
German Democratic Republic
Prior art keywords
compounds
dihydro
formula
bromo
benzodiazepine
Prior art date
Application number
DD82243528A
Other languages
German (de)
English (en)
Inventor
Horst Zeugner
Michael Ruhland
Hans Liepmann
Wolfgang Milkowski
Herbert Muesch
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of DD203907A5 publication Critical patent/DD203907A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DD82243528A 1981-09-30 1982-09-27 Verfahren zur herstellung von 7-brom-5-(2-halogenphenyl)-1h-2,3 dihydro-1,4-benzodiazepin-verbindungen DD203907A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813138769 DE3138769A1 (de) 1981-09-30 1981-09-30 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD203907A5 true DD203907A5 (de) 1983-11-09

Family

ID=6142952

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82243528A DD203907A5 (de) 1981-09-30 1982-09-27 Verfahren zur herstellung von 7-brom-5-(2-halogenphenyl)-1h-2,3 dihydro-1,4-benzodiazepin-verbindungen

Country Status (20)

Country Link
US (1) US4505908A (xx)
EP (1) EP0075855B1 (xx)
JP (1) JPS5867678A (xx)
AT (1) ATE17123T1 (xx)
AU (1) AU553689B2 (xx)
CA (1) CA1196635A (xx)
DD (1) DD203907A5 (xx)
DE (2) DE3138769A1 (xx)
DK (1) DK156065C (xx)
ES (1) ES8306126A1 (xx)
FI (1) FI68047C (xx)
GR (1) GR77652B (xx)
HU (1) HU189179B (xx)
IE (1) IE53937B1 (xx)
IL (1) IL66890A (xx)
NO (1) NO157698C (xx)
NZ (1) NZ202036A (xx)
PH (1) PH18102A (xx)
PT (1) PT75553B (xx)
ZA (1) ZA827140B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221402A1 (de) * 1982-06-05 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
BR0014153A (pt) * 1999-08-27 2002-05-07 Procter & Gamble Componentes de intensificação de branqueamento, composições e métodos de lavagem
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
CN1384867A (zh) 1999-08-27 2002-12-11 宝洁公司 稳定性提高的配制组分、使用该组分的组合物和洗衣方法
JP2003508586A (ja) * 1999-08-27 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 迅速に作用する処方成分、それらの成分を使用する組成物および洗濯方法
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
US8752268B2 (en) 2006-05-26 2014-06-17 Abbott Cardiovascular Systems Inc. Method of making stents with radiopaque markers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244869A (en) * 1972-05-03 1981-01-13 Kali-Chemie A.G. Benzodiazepine derivatives and process of making them
DE2520937C3 (de) * 1975-05-10 1978-10-12 Kali-Chemie Ag, 3000 Hannover 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
ATE17123T1 (de) 1986-01-15
ZA827140B (en) 1983-07-27
EP0075855B1 (de) 1985-12-27
DK431782A (da) 1983-03-31
ES515774A0 (es) 1983-05-01
DK156065B (da) 1989-06-19
NZ202036A (en) 1985-02-28
AU8883882A (en) 1983-04-14
US4505908A (en) 1985-03-19
GR77652B (xx) 1984-09-25
EP0075855A3 (en) 1983-06-15
DK156065C (da) 1989-11-13
FI68047C (fi) 1985-07-10
AU553689B2 (en) 1986-07-24
NO157698C (no) 1988-05-04
IE53937B1 (en) 1989-04-26
ES8306126A1 (es) 1983-05-01
CA1196635A (en) 1985-11-12
EP0075855A2 (de) 1983-04-06
IL66890A (en) 1985-11-29
IE822362L (en) 1983-03-30
PT75553A (en) 1982-10-01
NO823265L (no) 1983-04-05
NO157698B (no) 1988-01-25
PH18102A (en) 1985-03-20
PT75553B (en) 1984-12-12
FI823338L (fi) 1983-03-31
DE3268156D1 (en) 1986-02-06
FI823338A0 (fi) 1982-09-29
HU189179B (en) 1986-06-30
DE3138769A1 (de) 1983-04-14
FI68047B (fi) 1985-03-29
JPS5867678A (ja) 1983-04-22
IL66890A0 (en) 1982-12-31
JPH0433791B2 (xx) 1992-06-04

Similar Documents

Publication Publication Date Title
EP0005205B1 (de) Substituierte 5,6-Dimethylpyrrolo(2,3-d)pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0031080B1 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0059387A2 (de) Imidazodiazepine, Verfahren und Zwischenprodukte zu ihrer Herstellung, sowie diese enthaltende Arzneimittel
EP0075855B1 (de) 7-Brom-5-(2-halogenphenyl)-1H-2,3-dihydro-1,4-benzodiazepin-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2125634A1 (de) Verfahren zur Herstellung von neuen Cycloheptenderivaten
DE3402060A1 (de) Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE68913367T2 (de) Benzazepinderivate.
EP0213293B1 (de) In 11-Stellung substituierte 5,11-Dihydro-6H-pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zur ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0024272B1 (de) 1,4-Benzodiazepinderivate und ihre Salze; Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE1668634B2 (xx)
DE2719607C2 (xx)
EP0054839B1 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0002672A2 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2242059A1 (de) 2,4-dihydro-1h-s-triazolo eckige klammer auf 4,3-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepine und verfahren zu ihrer herstellung
DE2002882A1 (de) Benzodiazepin-Derivate
EP0059388A1 (de) Imidazodiazepine, Verfahren und Zwischenprodukte zu deren Herstellung, sowie diese enthaltende Arzneimittel
DE3217236C2 (de) 5,6-Dihydro-11H-dibenzo [b,e]- azepin-6-one, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE1952486C2 (xx)
EP0072029B1 (de) Triazolobenzazepine, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel
EP0086980B1 (de) Substituierte Dibenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0050212A1 (de) 5-Substituierte 9-Cyanmethylen-dithieno(3,4-b:4'.3'-e)-azepine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
DE3221402A1 (de) 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
EP0030015B1 (de) Triazolobenzazepine, Zwischenprodukte und Verfahren zu ihrer Herstellung, sowie diese enthaltende Präparate
DE3124013A1 (de) 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0084155A2 (de) (1,2)-anellierte 1,4-Benzodiazepin-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee